Antiviral effect of Bosentan and Valsartan during coxsackievirus B3 infection of human endothelial cells

Telmisartan Increases the Permeability of Endothelial Cells through Zonula Occludens-1

(2009) Chang Bian et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Tissue-Specific Deletion of the Coxsackievirus and Adenovirus Receptor Protects Mice from Virus-Induced Pancreatitis and Myocarditis

(2009) Nicole L. Kallewaard et al.   Cell Host & Microbe

Prevention of Cardiac Dysfunction in Acute Coxsackievirus B3 Cardiomyopathy by Inducible Expression of a Soluble Coxsackievirus-Adenovirus Receptor

(2009) Sandra Pinkert et al.   CIRCULATION

Viral Myocarditis

(2009) Toshitaka Yajima et al.   CIRCULATION

Bosentan Enhances Viral Load via Endothelin-1 Receptor Type-A–Mediated p38 Mitogen-Activated Protein Kinase Activation While Improving Cardiac Function During Coxsackievirus-Induced Myocarditis

(2009) David Marchant et al.   CIRCULATION RESEARCH

Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension

(2009) Martha Kingman et al.   EXPERT OPINION ON PHARMACOTHERAPY

Cardiac Deletion of the Coxsackievirus-Adenovirus Receptor Abolishes Coxsackievirus B3 Infection and Prevents Myocarditis In Vivo

(2009) Yu Shi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dynamin- and Lipid Raft-Dependent Entry of Decay-Accelerating Factor (DAF)-Binding and Non-DAF-Binding Coxsackieviruses into Nonpolarized Cells

(2009) K. P. Patel et al.   JOURNAL OF VIROLOGY

Acute viral myocarditis

(2008) R. Dennert et al.   EUROPEAN HEART JOURNAL

The tight junction protein CAR regulates cardiac conduction and cell–cell communication

(2008) Ulrike Lisewski et al.   JOURNAL OF EXPERIMENTAL MEDICINE